Results 161 to 170 of about 730,384 (247)

Hepatitis B Vaccination Coverage and Associated Factors Among Healthcare Workers: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Hepatitis B virus (HBV) infection is a major occupational hazard among healthcare workers (HCWs), particularly in resource‐limited settings where vaccination coverage remains low. This study aimed to assess hepatitis B vaccination coverage and associated factors among healthcare workers.
Melaku Zewdu Yehualaw   +7 more
wiley   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

open access: yesInternational Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita   +13 more
wiley   +1 more source

Moving beyond a legacy paradigm: A vision for equitable access to quality medicines in Africa

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S44-S50, June 2026.
Abstract Ensuring the availability of quality medicines is fundamental to achieving health outcomes and safeguarding public health. However, in many low‐ and middle‐income countries, especially across Africa, the current quality assurance paradigm—largely driven by historical donor preferences for WHO prequalification and stringent regulatory authority
Naoko Doi   +9 more
wiley   +1 more source

Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIV

open access: yesJournal of the International AIDS Society, Volume 29, Issue S1, June 2026.
ABSTRACT Introduction Dolutegravir (DTG) is a key antiretroviral (ARV) drug for children living with HIV, but no specific formulation is available for neonates (<28 days old). One of the DTG formulations evaluated in the PETITE‐DTG trial was a novel 5 mg oral DTG dispersible film (DTG‐Film).
Lario Viljoen   +9 more
wiley   +1 more source

Scientists' Warning to Humanity: Unnecessary Bureaucracy Is a Global Impediment to Productivity, Advancement of Human and Planetary Wellbeing, Science and Sustainability

open access: yesMicrobial Biotechnology, Volume 19, Issue 6, June 2026.
Unnecessary bureaucracy is a global impediment to progress and productivity that increases stress and lowers workplace morale and motivation. In research it smothers creativity and innovation that are key to new discoveries and the societal and environmental benefits they catalyse.
Kenneth Timmis   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy